Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StopCAD trial: High-dose statin vs low-dose statin plus ezetimibe in stable coronary artery disease
KCT0004325Phase 4Recruiting
- Sponsor
- Yuhan
- Start
- Jul 2019
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of ulinastatin and ezetimibe in coronary arteriosclerosis (2 arms), sponsored by Yuhan. Primary endpoint: Change in coronary atherosclerotic plaque characteristics. Started Jul 2019; status: recruiting.
02
Drugs
ulinastatinezetimibe
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on KCT0004325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004325.